Shares of Structure Therapeutics Inc ADR (NASDAQ: GPCR) climbed 6.8% following the news that Pfizer Inc. (NYSE: NYSE:PFE) has discontinued the development of its obesity drug candidate, danuglipron.

Former NHLer turned analyst Martin Biron joined That's Hockey to discuss.

Digital portal of the STAR Group of Publications: Delivers the latest news and views, multimedia, analyses and in-depth reports on the Philippines, sports, business, entertainment, lifestyle and ...

Alongside the steepening of the curve, interest-rate swaps have extended their recent extreme outperformance of Treasury securities as traders sought to avoid costs associated with holding bonds.